Equities

Biolidics Ltd

Biolidics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (SGD)0.011
  • Today's Change0.00 / 0.00%
  • Shares traded491.00k
  • 1 Year change-31.25%
  • Beta0.4917
Data delayed at least 10 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, marketing, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. It has three segments: cancer diagnostics, infectious diseases and laboratory services. Cancer diagnostics segment develops and commercializes the ClearCell FX1 System, a fully automated CE-IVD medical device, which separate and enrich cancer cells from blood, allows users of the system to perform liquid biopsies. Infectious diseases segment develops, markets and/or distributes certified test kits with various diagnostic partners. Laboratory services segment offers a range of tests. The laboratory has a regulatory approval from Singapore’s Ministry of Health for molecular microbiology testing and PCR testing services for COVID-19 in Singapore.

  • Revenue in SGD (TTM)1.32m
  • Net income in SGD-2.49m
  • Incorporated2009
  • Employees15.00
  • Location
    Biolidics Ltd37 Jalan Pemimpin, #02-07 MapexSINGAPORE 577177SingaporeSGP
  • Phone+65 64820668
  • Fax+65 64820778
  • Websitehttps://www.biolidics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
US Nuclear Corp3.00m-4.62m5.67m--------1.89-0.0949-0.09490.0621-0.04940.7480.69036.44---115.12-93.36---392.4341.4346.78-153.91-119.560.1067-0.97888.81--6.68-9.30-66.73---31.69--
Robot SA6.57m-80.29k5.67m----0.72698.600.8634-0.0194-0.01941.601.870.39282.381.42---0.48-0.3968-0.7021-0.49810.4113.11-1.22-1.111.050.02090.5326--16.874.16-152.12---21.86--
Reflect Scientific Inc1.45m-617.71k6.16m7.00--2.42--4.24-0.0054-0.00540.01270.02210.42230.54679.10154,307.10-17.9511.10-21.0113.2155.2262.48-42.5010.002.34--0.00---47.09-6.99-613.46------
Thermogenesis Holdings Inc12.71m-24.19m6.28m25.00------0.4942-8.60-8.603.99-0.46080.6173.176.71377,800.00-123.58-78.08-369.62-133.9420.4429.01-200.31-133.660.3209-0.65531.88---9.90-0.4739-59.49--6.96--
Insplorion AB356.83k-2.85m6.81m12.00--2.09--19.09-2.52-2.520.18711.090.0797-2.105.58218,538.50-63.67-29.27-74.89-34.48238.58260.36-799.37-791.031.63--0.0409---2.70-4.88-14.18--12.48--
Luxxu Group Ltd5.90m-7.37m7.44m56.00--0.4855--1.26-0.0793-0.07930.06350.16480.23560.59830.8658611,163.50-29.42-33.26-33.95-35.127.795.23-124.85-126.114.40-4.040.2545---50.83-21.6118.06------
Dorsavi Ltd1.32m-1.39m7.52m34.00--5.96--5.68-0.0029-0.00290.00270.00240.62470.42281.87---65.84-60.69-97.79-88.7184.5888.19-105.38-165.451.83-62.210.1012---25.62-14.77-18.52---52.15--
Mantex AB857.85k-2.02m7.55m----2.76--8.80-0.0788-0.07880.03320.08670.23980.248842.92---56.37-64.71-64.06-76.8279.0563.54-235.05-300.724.43-69.720.1601--373.264.57-3.37------
Biolidics Ltd1.32m-2.49m8.19m15.00------6.23-0.0041-0.00410.0022-0.0030.388531.264.4787,666.66-73.50-51.21---69.1954.8341.13-189.20-165.860.2182-21.1759.50---47.170.73273.46------
Hanvey Group Holdings Ltd32.02m-3.41m8.25m110.00--2.56--0.2577-0.1196-0.11961.120.11320.82845.049.311,687,882.00-8.89-6.91-23.71-19.1423.3324.18-10.74-7.460.9283-1.070.8947---31.880.3471-85.65---39.81--
Memphasys Ltd42.42k-4.07m9.85m24.00--1.37--232.31-0.0046-0.00460.000050.00590.00330.2732-----31.43-16.26-46.11-19.7344.48---9,600.13-21,518.040.1368-11.780.456---43.39---63.43--8.14--
Telesis Bio Inc33.15m-63.42m10.13m137.00------0.3055-28.31-28.3114.8012.940.32313.275.58179,802.90-59.34---67.10--60.43---183.66--3.08-35.890.2015--0.2697---1.14------
Aurora Solar Technologies Inc10.56m-1.71m10.98m----1.88--1.04-0.0098-0.00980.05050.02660.91081.517.98---14.71-82.57-22.77-106.4452.4143.93-16.15-135.081.22-39.660.0665----17.05-5.49--13.30--
Data as of May 16 2024. Currency figures normalised to Biolidics Ltd's reporting currency: Singapore Dollar SGD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.